Progestogen therapy for advanced carcinoma of the endometrium.
D000230:Adenocarcinoma / Q000473:pathology; D000328:Adult; D000368:Aged; D002294:Carcinoma, Squamous Cell / Q000473:pathology; D004717:Endometrium; D005260:Female; D006801:Humans; D008207:Lymphatic Metastasis; D008525:Medroxyprogesterone / Q000627:therapeutic use*; D008875:Middle Aged; D009362:Neoplasm Metastasis; D009640:Norethindrone / Q000627:therapeutic use*; D011374:Progesterone / Q000627:therapeutic use*; D013997:Time Factors; D014594:Uterine Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy
D011374:Progesterone; D008525:Medroxyprogesterone; D009640:Norethindrone